HH&L Acquisition Co.
We intend to focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value.
(Note: HH&L Acquisition priced its IPO on Feb. 5, 2021, on upsized terms: 36 million units, up from 30 million in the prospectus, at $10 each to raise $360 million.)
|Address||Suite 3508, One Exchange Square 8 Connaught Place Central, Hong Kong|
|Phone Number||(852) 3752 2870|
|View Prospectus:||HH&L Acquisition Co.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$360.0 mil|
|Manager / Joint Managers||Goldman Sachs (Asia)/ Credit Suisse|
|Expected To Trade:||2/5/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|